Brief: Ryvu Therapeutics Says Its Project Recommended For Funding By Medical Research Agency
07/02/2025 07:16
Feb 7 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* PROJECT RECOMMENDED FOR FUNDING BY MEDICAL RESEARCH AGENCY
* PROJECT TOTAL NET VALUE IS PLN 9.63 MILLION
* RECOMMENDED FUNDING AMOUNT IS PLN 7.23 MILLION
Source text: urn:newsml:reuters.com:*:nEM11LrlGa
Further company coverage: RVU.WA
(Reporting by Gdańsk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys